咨询与建议

看过本文的还看了

相关文献

该作者的其他文献

文献详情 >Impact of antiretroviral thera... 收藏

Impact of antiretroviral therapy on lipid metabolism of human immunodeficiency virus-infected patients: Old and new drugs

作     者:Joel da Cunha Luciana Morganti Ferreira Maselli Ana Carolina Bassi Stern Celso Spada Sérgio Paulo Bydlowski 

作者机构:Laboratory of Genetics and Molecular Hematology(LIM31)University of Sao Paulo Medical School(FMUSP)Sao Paulo SP 05403-000Brazil Clinical Analysis DepartmentHealth Sciences CenterFederal University of Santa Catarina(CCS/UFSC)Florianopolis SC 88040-900BraZIL Molecular Genetics and Biotechnology DepartmentResearch DivisionPró-Sangue Foundation/Blood Center of Sao PauloSao Paulo SP 05403-000Brazil 

出 版 物:《World Journal of Virology》 (世界病毒学杂志)

年 卷 期:2015年第4卷第2期

页      面:56-77页

学科分类:10[医学] 

基  金:financially supported in the our laboratory with resources from The National Council of Technological and Scientific Development the State of Sao Paulo Research Foundation the National Institute of Science and Technology of Complex Fluids 

主  题:Human immunodeficiency virus-1 infection Highly active antiretroviral therapy Protease inhibitors Dyslipidemia Atherosclerosis Lipodystrophy Statins Fibrates Diet Lifestyle 

摘      要:For human immunodeficiency virus(HIV)-infected patients, the 1990s were marked by the introduction of highly active antiretroviral therapy(HAART) representing a new perspective of life for these patients. The use of HAART was shown to effectively suppress the replication of HIV-1 and dramatically reduce mortality and morbidity, which led to a better and longer quality of life for HIV-1-infected patients. Apart from the substantial benefits that result from the use of various HAART regimens, laboratory and clinical experience has shown that HAART can induce severe and considerable adverse effects related to metabolic complications of lipid metabolism, characterized by signs of lipodystrophy, insulin resistance, central adiposity, dyslipidemia, increased risk of cardiovascular disease and even an increased risk of atherosclerosis. New drugs are being studied, new therapeutic strategies are being implemented, and the use of statins, fibrates, and inhibitors of intestinal cholesterol absorption have been effective alternatives. Changes in diet and lifestyle have also shown satisfactory results.

读者评论 与其他读者分享你的观点

用户名:未登录
我的评分